Anti-Bevacizumab (Human) ELISA Kit

Product Overview

A sandwich ELISA kit for the quantitative measurement of Anti-Bevacizumab in Human serum and plasma.

Bevacizumab (Avastin®) is a recombinant human IgG1 monoclonal antibody specific for all human vascular endothelial growth factor-A (VEGF-A) isoforms. It has been demonstrated that bevacizumab, in combination with chemotherapy, resulted in increased survival in patients with previously untreated metastatic colorectal cancer relative to chemotherapy alone, leading to FDA approval of the first anti-angiogenic agent. However, some patients develop unwanted immunogenicity, which leads to production of anti-drug-antibodies (ADAs) inactivating the therapeutic effects of the treatment and, in rare cases, inducing adverse effects. 96Trace’s BioSimTM anti-Bevacizumab ELISA kit is designed to quantify/measure the antibody against Bevacizumab with high specificity and sensitivity in biological matrices.

Assay Information

Performance Data

Applications

This ELISA kit is used for quantitative measurement of antibody against Bevacizumab in human serum and plasma

Features & Benefits

• Designed for quantitative measurement of Anti-Bevacizumab.
• Assay format: Sandwich ELISA.
• Sample type: Human serum and plasma.
• Detection method: Absorbance (450 nm).
• Detection Range: 62 - 500 ng/ml
• Sensitivity: 30 ng/ml
• Kit size: 96 Well.

Storage & Shipping

Product Details